Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Janet Prameela Dsouza, Jyothi Chakrabarty, Padmakumar Ramachandran, Vasudeva Guddattu, Baby S Nayak & Anice George. (2022) Effectiveness of a Nursing Intervention Module on Adherence, Knowledge, Quality of Life, and Complications Among Patients Receiving Anticoagulation therapy—a Randomized Controlled Trial Protocol. Patient Preference and Adherence 16, pages 1723-1731.
Read now
Read now
Anders Larsson, Roman Greig-Pylypczuk & Albert Huisman. (2015) The state of point-of-care testing: a european perspective. Upsala Journal of Medical Sciences 120:1, pages 1-10.
Read now
Read now
Cecilia Johansson, Lovisa Hägg, Lars Johansson & Jan-Håkan Jansson. (2014) Characterization of patients with atrial fibrillation not treated with oral anticoagulants. Scandinavian Journal of Primary Health Care 32:4, pages 226-231.
Read now
Read now
Hans-Christoph Diener, Sophia Stanford, Azmil Abdul-Rahim, Louisa Christensen, Kristina Dupont Hougaard, Ameet Bakhai, Roland Veltkamp & Hans Worthmann. (2014) Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhage. Expert Review of Neurotherapeutics 14:9, pages 1019-1028.
Read now
Read now
Irma Virjo, Kari Mäkelä, Juhani Aho, Pentti Kalliola, Harri Kurunmäki, Leena Uusitalo, Markku Valli & Suvi Ylinen. (2010) Who receives anticoagulant treatment with warfarin and why? A population-based study in Finland. Scandinavian Journal of Primary Health Care 28:4, pages 237-241.
Read now
Read now
Articles from other publishers (31)
Mehmet EKİZ, Latif DURAN, Hızır Ufuk AKDEMİR & İskender AKSOY. (2021) THE FACTORS ASSOCIATED WITH BLEEDING IN PATIENTS USING WARFARINVarfarin Kullanan Hastalarda Kanama ile İlişkili Faktörler. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 23:3, pages 482-491.
Crossref
Crossref
Aykut DEMİRKIRAN, A BASTURK & Şamil ECİRLİ. (2021) Determination of the Risk Factors in Patients Admitted with Bleeding Due to Warfarin use and Evaluation of the Current Bleeding Risk Scores. OSMANGAZİ JOURNAL OF MEDICINE.
Crossref
Crossref
Robbert Bipat. 2020. Phytochemicals in Human Health. Phytochemicals in Human Health.
Daniel M. Witt, Robby Nieuwlaat, Nathan P. Clark, Jack Ansell, Anne Holbrook, Jane Skov, Nadine Shehab, Juliet Mock, Tarra Myers, Francesco Dentali, Mark A. Crowther, Arnav Agarwal, Meha Bhatt, Rasha Khatib, John J. Riva, Yuan Zhang & Gordon Guyatt. (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Advances 2:22, pages 3257-3291.
Crossref
Crossref
Luca Zanella, Giacomo Zoppellaro, Lucia Marigo, Gentian Denas, Seena Padayattil Jose & Vittorio Pengo. (2018) Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control study. Cardiovascular Therapeutics 36:5, pages e12458.
Crossref
Crossref
Hua Cao, Jianmei Wu & Jinhua Zhang. (2018) Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic. International Journal of Clinical Pharmacy 40:5, pages 1072-1077.
Crossref
Crossref
Nijole Bernaitis, Tony Badrick & Shailendra Anoopkumar-Dukie. (2018) Dedicated warfarin care programme results in superior warfarin control in Queensland, Australia. International Journal of Clinical Practice 72:3, pages e13051.
Crossref
Crossref
A. Yu. Krylov, A. M. Shulutko & S. E. Khmyrova. (2018) The Perioperative Management of the Patient Presenting with Varicose Veins Concomitant with Prolonged Warfarin Therapy. Flebologiia 12:3, pages 142.
Crossref
Crossref
A. Yu. Krylov, A. M. Shulutko, A. A. Petrovskaya, N. V. Prasolov & S. E. Khmyrova. (2018) Management of Bleedings and Recurrent Venous Thromboembolism in Patients Receiving Vitamin K Antagonists. Flebologiia 12:1, pages 50.
Crossref
Crossref
V. Barrios, M.I. Egocheaga-Cabello, J. Gállego-Culleré, E. Ignacio-García, L. Manzano-Espinosa, A. Martín-Martínez, J. Mateo-Arranz, J. Polo-García & D. Vargas-Ortega. (2017) Healthcare resources and needs in anticoagulant therapy for patients with nonvalvular atrial fibrillation. SAMOA Study. Revista Clínica Española (English Edition) 217:4, pages 193-200.
Crossref
Crossref
V. Barrios, M.I. Egocheaga-Cabello, J. Gállego-Culleré, E. Ignacio-García, L. Manzano-Espinosa, A. Martín-Martínez, J. Mateo-Arranz, J. Polo-García & D. Vargas-Ortega. (2017) Recursos y necesidades asistenciales en el tratamiento anticoagulante de los pacientes con fibrilación auricular no valvular. Estudio SAMOA. Revista Clínica Española 217:4, pages 193-200.
Crossref
Crossref
Charles E. Leonard, Colleen M. Brensinger, Warren B. Bilker, Stephen E. Kimmel, Xu Han, Young Hee Nam, Joshua J. Gagne, Margaret J. Mangaali & Sean Hennessy. (2017) Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics. International Journal of Cardiology 228, pages 761-770.
Crossref
Crossref
Fredrik Björck, Agnes Ek, Lars Johansson & Anders Själander. (2016) Warfarin persistence among atrial fibrillation patients - why is treatment ended?. Cardiovascular Therapeutics 34:6, pages 468-474.
Crossref
Crossref
Étienne Rouleau-Mailloux, Payman Shahabi, Stéphanie Dumas, Yassamin Feroz Zada, Sylvie Provost, Jason Hu, Jacqueline Nguyen, Nawal Bouchama, Ian Mongrain, Mario Talajic, Jean-Claude Tardif, Sylvie Perreault & Marie-Pierre Dubé. (2015) Impact of regular physical activity on weekly warfarin dose requirement. Journal of Thrombosis and Thrombolysis 41:2, pages 328-335.
Crossref
Crossref
Fredrik Björck, Per Sandén, Henrik Renlund, Peter J. Svensson & Anders Själander. (2015) Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden. Thrombosis Research 136:2, pages 216-220.
Crossref
Crossref
Thomas Davidson, Ann Lindelöf, Torbjörn Wallén, Tomas L Lindahl & Claes Hallert. (2015) Point-of-care monitoring of warfarin treatment in community dwelling elderly – A randomised controlled study. Journal of Telemedicine and Telecare 21:5, pages 298-301.
Crossref
Crossref
Kerstin Arbring, Srinivas Uppugunduri & Tomas L Lindahl. (2013) Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics. BMC Health Services Research 13:1.
Crossref
Crossref
Marcus Lind, Jan-Håkan Jansson, Torbjörn K. Nilsson, Lisbeth Slunga Järvholm & Lars Johansson. (2013) Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment. Thrombosis Research 132:2, pages e77-e82.
Crossref
Crossref
Ivar Dimberg, Bartosz Grzymala-Lubanski, Anette Hägerfelth, Mårten Rosenqvist, Peter Svensson & Anders Själander. (2012) Computerised assistance for warfarin dosage — Effects on treatment quality. European Journal of Internal Medicine 23:8, pages 742-744.
Crossref
Crossref
Talitha I Verhoef, William K Redekop, Rianne MF van Schie, Samira Bayat, Ann K Daly, Mary Geitona, Elisabeth Haschke-Becher, Dyfrig A Hughes, Farhad Kamali, Lars-Åke Levin, Vangelis G Manolopoulos, Munir Pirmohamed, Uwe Siebert, Julia C Stingl, Mia Wadelius, Anthonius de Boer & Anke-Hilse Maitland-van der Zee. (2012) Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs. Pharmacogenomics 13:12, pages 1405-1417.
Crossref
Crossref
Kurt Boman, Thomas Davidson, Mats Gustavsson, Mona Olofsson, Gun-Britt Renström & Lars Johansson. (2012) Telemedicine improves the monitoring process in anticoagulant treatment. Journal of Telemedicine and Telecare 18:6, pages 312-316.
Crossref
Crossref
Liat Mlynarsky, Idit Bejarano-Achache, Mordechai Muszkat & Yoseph Caraco. (2011) Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers. European Journal of Clinical Pharmacology 68:5, pages 617-627.
Crossref
Crossref
M. Lind, K. Boman, L. Johansson, T. K. Nilsson, L. Slunga Järvholm & J.‐H. Jansson. (2011) Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment. Journal of Internal Medicine 271:3, pages 239-246.
Crossref
Crossref
Anne Holbrook, Sam Schulman, Daniel M. Witt, Per Olav Vandvik, Jason Fish, Michael J. Kovacs, Peter J. Svensson, David L. Veenstra, Mark Crowther & Gordon H. Guyatt. (2012) Evidence-Based Management of Anticoagulant Therapy. Chest 141:2, pages e152S-e184S.
Crossref
Crossref
M. Wieloch, A. Sjalander, V. Frykman, M. Rosenqvist, N. Eriksson & P. J. Svensson. (2011) Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA. European Heart Journal 32:18, pages 2282-2289.
Crossref
Crossref
W. T. Chen, C. Michael White, O. J. Phung, J. Kluger, A. Ashaye, D. Sobieraj, S. Makanji, V. Tongbram, W. L. Baker & C. I. Coleman. (2011) Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review. International Journal of Clinical Practice 65:7, pages 749-763.
Crossref
Crossref
Wendy T. Chen, C. Michael White, Olivia J. Phung, Jeffrey Kluger, Ajibade O. Ashaye, Diana M. Sobieraj, Sagar Makanji, Vanita Tongbram, William L. Baker & Craig I. Coleman. (2011) Association Between CHADS2 Risk Factors and Anticoagulation-Related Bleeding: A Systematic Literature Review. Mayo Clinic Proceedings 86:6, pages 509-521.
Crossref
Crossref
Thomas P. Moyer, Dennis J. O'Kane, Linnea M. Baudhuin, Carmen L. Wiley, Alexandre Fortini, Pamela K. Fisher, Denise M. Dupras, Rajeev Chaudhry, Prabin Thapa, Alan R. Zinsmeister & John A. Heit. (2009) Warfarin Sensitivity Genotyping: A Review of the Literature and Summary of Patient Experience. Mayo Clinic Proceedings 84:12, pages 1079-1094.
Crossref
Crossref
Joan-Carles Trullas-Vila, Josep Bisbe-Company, Adriana Freitas-Ramírez, Silvia Soler-Simon, Vicenta Bisbe-Company, Josep-Maria Roncero-Vidal & Rosa Gispert-Magarolas. (2009) Ten-year experience with acenocoumarol treatment in an ambulatory cohort of Spanish patients. Journal of Thrombosis and Thrombolysis 28:4, pages 436-443.
Crossref
Crossref
Tammy J. Bungard, Leslie Gardner, Stephen L. Archer, Peter Hamilton, Bruce Ritchie, Wayne Tymchak & Ross T. Tsuyuki. (2008) Impact of a pharmacist-managed anticoagulation clinic on clinical events. Canadian Pharmacists Journal 141:5, pages 278-284.
Crossref
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:12.
Crossref
Crossref